But to stay on the obesity side of it and the lifestyle side of it does the behavioral phenotyping that you've done, as you began to understand that there is a sort of biological component you're working against here, does that behavioral phenotyping become then more important
With this move, Novo Nordisk strengthens its GLP-1 portfolio in India, where it already markets Rybelsus (oral semaglutide) and Wegovy (obesity management)and enters a competitive space as Eli Lillys Mounjaro is also making inroads
The oral semaglutide will cost Rs 315 (USD 3.82) per pill, or around Rs 10000 (USD 121.40) for a full month of treatment
Aim for 1.2 to 1.6 grams of protein per kilogram of body weight daily, spread across three to four meals
doi: 10.1038/ijo.2015.172 17 DeaconCFHolstJJ
The MHRA has not approved any GLP-1 receptor agonist for use below the labelled doses, and this approach falls outside current prescribing guidelines